BU-NOT-SET

CONTACT US
2023: fill and finish demand expected to continue as the industry faces new challenges
  • Drug product
  • Industry trends
CDMO insight
Insight
What does 2023 hold for oral solid dosage forms?
  • Drug product
  • Industry trends
2023 oral solid dose
Insight
Is it time to introduce science based targets for climate change?
  • Sustainability
science based targets
Insight
Addressing the key pitfalls hindering technology transfer success
  • Drug product
  • Industry trends
Pills
Insight
Overcoming tablet dissolution challenges with formulation expertise
  • Analytical chemistry
  • Drug product
Pills
Case study
Today’s potent oral dose forms require flexible manufacturing environments
  • Industry trends
  • Manufacturing
Manufacturing tablets
Insight
Benefits of reformulation strategies
  • Analytical chemistry
  • Drug product
Benefits of reformulation strategies
Insight
Supporting first lyophilised mRNA vaccine to pivotal trial
  • Drug product
  • Manufacturing
Hand holding vial
Case study
LAB+ blow-fill-seal system
  • Drug product
  • Manufacturing
Lab+ machine
Fact sheet
Insight
  • Analytical chemistry
The QbD approach: Key advantages in clinical and commercial phases
Report
  • Sustainability
Sustainability report 2020
Poster
  • Drug substance
Recipharm and Oncopeptides: Successful collaboration in the development of melflufen, a peptidase-potentiated alkylating agent in clinical trials
Fact sheet
  • Analytical chemistry
Recipharm Analytical Solutions™
Fact sheet
  • Analytical chemistry
Impurity identification
Fact sheet
  • Analytical chemistry
Stability studies
Fact sheet
  • Analytical chemistry
Extractables & leachables testing
Insight
  • Industry trends
Pharmaceutical mergers and acquisitions: opportunities and drivers for CDMOs
Insight
  • Industry trends
Global expansion in the CDMO field